Line 69: | Line 69: | ||
<meta name="HandheldFriendly" content="True" /> | <meta name="HandheldFriendly" content="True" /> | ||
<meta name="MobileOptimized" content="320" /> | <meta name="MobileOptimized" content="320" /> | ||
− | + | <meta name="viewport" content="width=device-width, initial-scale=1.0",minimum-scale=0.2, maximum-scale=2.0, user-scalable=yes" /> | |
<meta content="on" http-equiv="cleartype" /> | <meta content="on" http-equiv="cleartype" /> | ||
<meta property="og:title" content="Home" /> | <meta property="og:title" content="Home" /> | ||
Line 88: | Line 88: | ||
<div class="inner-wrap"> | <div class="inner-wrap"> | ||
<!-- Off Canvas Menu --> | <!-- Off Canvas Menu --> | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
<!-- close the off-canvas menu --> | <!-- close the off-canvas menu --> | ||
<a class="exit-off-canvas"></a> | <a class="exit-off-canvas"></a> | ||
Line 152: | Line 115: | ||
<a class="nav-global__link" title="" href="#">AWARDS</a></li> | <a class="nav-global__link" title="" href="#">AWARDS</a></li> | ||
</ul> | </ul> | ||
− | <style>#menu06{width:200px;right:0px;} #menu07{width:200px;right:0px;} | + | <style> |
+ | .content{ | ||
+ | box-shadow: 6px 6px 3px #888888; | ||
+ | } | ||
+ | #menu06{width:200px;right:0px;} #menu07{width:200px;right:0px;} | ||
#menu01 .arrow-up{margin-right:6.429rem;} | #menu01 .arrow-up{margin-right:6.429rem;} | ||
#menu02 .arrow-up{margin-right:90px;} #menu03 .arrow-up{margin-right:90px;} #menu06 .arrow-up{margin-right:120px;} #menu07 .arrow-up{margin-right:27px;} #menu01{width:200px;right:31rem;} #menu02{width:200px;right:27rem;} #menu03{width:200px;right:21.3rem;} | #menu02 .arrow-up{margin-right:90px;} #menu03 .arrow-up{margin-right:90px;} #menu06 .arrow-up{margin-right:120px;} #menu07 .arrow-up{margin-right:27px;} #menu01{width:200px;right:31rem;} #menu02{width:200px;right:27rem;} #menu03{width:200px;right:21.3rem;} | ||
Line 322: | Line 289: | ||
</div> | </div> | ||
</nav> | </nav> | ||
− | <style>.nav-global ul li a{ font-size:0.85rem; } @media screen and (max-width: 865px) { .nav-global ul li a{ font-size:0.85rem; } }</style> | + | <style>.nav-global ul li a{ font-size:0.85rem; } @media screen and (max-width: 865px) { .nav-global ul li a{ font-size:0.85rem; } } |
+ | |||
+ | #feature{ | ||
+ | background-size:100%; | ||
+ | } | ||
+ | @media screen and (max-width: 1200px) { | ||
+ | #feature{ | ||
+ | background-size:1200px; | ||
+ | } | ||
+ | } | ||
+ | </style> | ||
<div class="breadcrumb-share-wrap"> | <div class="breadcrumb-share-wrap"> | ||
Line 335: | Line 312: | ||
<!-- end .row --></div> | <!-- end .row --></div> | ||
<!-- end #header-outer-wrap--> | <!-- end #header-outer-wrap--> | ||
− | <div id="feature" class="row collapse text-light feature-footer-active"> | + | <div id="feature" class="row collapse text-light feature-footer-active" style="background-color: rgb(3,13,38);background-image:url(https://static.igem.org/mediawiki/2016/thumb/3/3f/NUDT_CHINA2016_FILES-img-banner-3.0.png/800px-NUDT_CHINA2016_FILES-img-banner-3.0.png);background-position:0px -350px;background-repeat:no-repeat;"> |
<div class="inner-wrap medium-24 columns"> | <div class="inner-wrap medium-24 columns"> | ||
<!--TYPO3SEARCH_begin--> | <!--TYPO3SEARCH_begin--> | ||
Line 341: | Line 318: | ||
<div class="carousel " id="slideshow-4811" data-cycle-log="false" data-cycle-auto-height="calc" data-cycle-prev="#prev-4811" data-cycle-next="#next-4811" data-cycle-pager="#cycle-pager-4811" data-cycle-easing="easeInOutQuad" data-cycle-fx="scrollVertUp" data-cycle-center-horz="true" data-cycle-speed="1000" data-cycle-timeout="8000" data-cycle-paused="true" data-cycle-slides="> div.slide"> | <div class="carousel " id="slideshow-4811" data-cycle-log="false" data-cycle-auto-height="calc" data-cycle-prev="#prev-4811" data-cycle-next="#next-4811" data-cycle-pager="#cycle-pager-4811" data-cycle-easing="easeInOutQuad" data-cycle-fx="scrollVertUp" data-cycle-center-horz="true" data-cycle-speed="1000" data-cycle-timeout="8000" data-cycle-paused="true" data-cycle-slides="> div.slide"> | ||
<div class="slide first"> | <div class="slide first"> | ||
− | <link rel="stylesheet" href="/Team | + | <link rel="stylesheet" href="/Team--NUDT_CHINA/CSS3.css" /> |
<!-- Quick initialize with theme color from first slide --> | <!-- Quick initialize with theme color from first slide --> | ||
<div class="row collapse " id="c6601" data-theme-class="bh-color__theme-c6601"> | <div class="row collapse " id="c6601" data-theme-class="bh-color__theme-c6601"> | ||
<div class="columns"> | <div class="columns"> | ||
− | <section class="big-header bh__height-size-3 text-light bh__video"> | + | <section class="big-header bh__height-size-3 text-light bh__video" style="height:300px;"> |
− | <div class="bh__background bh__background-color | + | <div class="bh__background bh__background-color "></div> |
− | <div class="bh__content-wrap"> | + | <div class="bh__content-wrap" style="height:120px;"> |
<div class="bh__content "> | <div class="bh__content "> | ||
<div class="bh__content-inner-wrap"> | <div class="bh__content-inner-wrap"> | ||
<!--h3 class="bh__subtitle"><a href="http#/explore/whats-here/exhibits/brick-by-brick/"><span class="line-wrap"><span class="line"><span class="bh__info">Exhibit / </span>Brick by Brick</span></span></a></h3--> | <!--h3 class="bh__subtitle"><a href="http#/explore/whats-here/exhibits/brick-by-brick/"><span class="line-wrap"><span class="line"><span class="bh__info">Exhibit / </span>Brick by Brick</span></span></a></h3--> | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
<h2 style="font-size:36px;" class="bh__title "> | <h2 style="font-size:36px;" class="bh__title "> | ||
<!--<a href="#">--> | <!--<a href="#">--> | ||
− | + | <span style="line-height:46px;" class="line-wrap"> | |
− | + | <span style="line-height:46px;" class="line">Development of A Novel</span></span> | |
− | + | <span style="line-height:46px;" class="line-wrap"> | |
− | + | <span style="line-height:46px;" class="line">Blood-MicroRNA Handy Detection System with CRISPR</span></span> | |
− | <!--</a>--> | + | <!--</a>--></h2> |
− | + | ||
</div> | </div> | ||
</div> | </div> | ||
Line 378: | Line 345: | ||
<div class="cycle-pager" id="cycle-pager-4811"></div> | <div class="cycle-pager" id="cycle-pager-4811"></div> | ||
</div> | </div> | ||
− | + | </div> | |
− | + | </div> | |
<!-- end #feature --> | <!-- end #feature --> | ||
<!-- end .columns --></div> | <!-- end .columns --></div> | ||
− | <div style="margin-top: | + | <div style="margin-top:20px;" id="content-wrap-ink"><!-- adjust in add_JS --> |
− | <div class="row footer-link" style=""> | + | <div class="row footer-link" style=""> |
+ | <div style="text-align:right;"><h5> | ||
+ | <a style="color:rgb(10,31,84);" href="/Team:NUDT_CHINA">HomePage</a> • | ||
+ | <!-- 修改这里!! -->Human Practice • | ||
+ | <a style="color:rgb(10,31,84);" href="/Team:NUDT_CHINA/Description"><!-- 修改这里!! -->Integrated Practices</a> | ||
+ | </h5><hr style="width:40%;margin-left:60%;border-top:1px solid rgb(10,31,84);" /></div> | ||
Line 392: | Line 364: | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | < | + | <!--在这里插入内容--> |
− | <span style=" | + | |
− | </span> | + | <h2> |
− | </ | + | <span><span style="color:#7f1015">NUDT_CHINA’s Human Practice Tour</span></span><hr /> |
+ | </h2> | ||
+ | <h3> | ||
+ | <span><span style="color:#7f1015">MAP</span></span> | ||
+ | </h3> | ||
+ | |||
</br> | </br> | ||
− | </ | + | </html> |
− | + | [[File:总结图2_NUDT_CHINA.jpg|700px|center]] | |
− | + | <html> | |
− | < | + | |
</br> | </br> | ||
− | + | <p> | |
− | + | <span style="line-height:2;font-family:Perpetua;font-size:16px;">(click figures to view details of our HP)</span> | |
− | <p | + | |
− | <span style="line-height:2;font-family:Perpetua;font-size: | + | |
</p> | </p> | ||
</br> | </br> | ||
− | |||
<p style="text-indent:22pt;"> | <p style="text-indent:22pt;"> | ||
− | <span style="line-height:2;font-family:Perpetua;font-size:18px;"> | + | <span style="line-height:2;font-family:Perpetua;font-size:18px;">This year we expanded our project to Human Practice in three places: Hospital&Health Center, Market and the Public. In each expansion we held meaningful activities closely related to our topic, and this turned out to be a nice interaction between the project and the practice. </span> |
</p> | </p> | ||
</br> | </br> | ||
− | |||
<p style="text-indent:22pt;"> | <p style="text-indent:22pt;"> | ||
− | <span style="line-height:2;font-family:Perpetua;font-size:18px;"> | + | <span style="line-height:2;font-family:Perpetua;font-size:18px;">Arrows in the map show our practice work in two directions.</span> |
</p> | </p> | ||
</br> | </br> | ||
− | |||
− | |||
− | |||
<p style="text-indent:22pt;"> | <p style="text-indent:22pt;"> | ||
− | <span style="line-height:2;font-family:Perpetua;font-size:18px;"> | + | <span style="line-height:2;font-family:Perpetua;font-size:18px;">Forward Arrows:What the project contributed to the world---a new medical application for Hospitals&Health Centers, a potential handy, low-cost early cancer detection method in the market, and cancer knowledge spreading&surveys and publicity conducted to the public.</span> |
</p> | </p> | ||
− | |||
− | + | </p> | |
− | + | ||
− | + | ||
<p style="text-indent:22pt;"> | <p style="text-indent:22pt;"> | ||
− | <span style="line-height:2;font-family:Perpetua;font-size:18px;"> | + | <span style="line-height:2;font-family:Perpetua;font-size:18px;">Backward Arrows:What we obtained from the world---we did consultation, sample collection and surveys in medical organizations, made a cost evaluation and market demands analysis in the market and got valuable feedback and suggestions from the public on the project. </span> |
</p> | </p> | ||
</br> | </br> | ||
− | |||
− | |||
</p> | </p> | ||
</br> | </br> | ||
<p style="text-indent:22pt;"> | <p style="text-indent:22pt;"> | ||
− | <span style="line-height:2;font-family:Perpetua;font-size:18px;"> | + | <span style="line-height:2;font-family:Perpetua;font-size:18px;">As a conclusion, we expanded the project to the practice to better serve the world with our creation, and at the same time search for suggestions from the world that could enhance our project. With the interactions between our project and the world, we felt the iGEM work this year was a big issue that influenced not only us, team NUDT_CHINA, but also people around us.</span> |
</p> | </p> | ||
</br> | </br> | ||
− | < | + | <h3> |
− | <span style=" | + | <span><span style="color:#7f1015">SCHEDULE</span></span> |
+ | </h3> | ||
</p> | </p> | ||
</br> | </br> | ||
− | + | ||
− | + | ||
− | + | ||
</br> | </br> | ||
− | </ | + | </html> |
− | + | [[File:时间轴——NUDT_CHINA.png|700px|center]] | |
− | + | <html> | |
− | < | + | |
</br> | </br> | ||
− | <p | + | <p> |
− | <span style="line-height:2;font-family:Perpetua;font-size: | + | <span style="line-height:2;font-family:Perpetua;font-size:16px;">:) Click boxes above to see our project & the practice. </span> |
</p> | </p> | ||
</br> | </br> | ||
+ | |||
<p style="text-indent:22pt;"> | <p style="text-indent:22pt;"> | ||
− | <span style="line-height:2;font-family:Perpetua;font-size:18px;"> | + | <span style="line-height:2;font-family:Perpetua;font-size:18px;">This is a specific guide of our practice work this year, listed with the time they were conducted. With our project starting and ending, the HP went on. </span> |
</p> | </p> | ||
</br> | </br> | ||
− | + | <h2 align="center" | |
+ | > | ||
+ | <span><span style="color:#7f1015">PART I</span></span> | ||
+ | </h2> | ||
+ | <h2 align="center" | ||
+ | > | ||
+ | <span><span style="color:#7f1015">COLLABORATIONS WITH HOSPITAL & HEALTH CENTER</span></span><hr /> | ||
+ | </h2> | ||
<p style="text-indent:22pt;"> | <p style="text-indent:22pt;"> | ||
− | <span style="line-height:2;font-family:Perpetua;font-size:18px;"> | + | <span style="line-height:2;font-family:Perpetua;font-size:18px;">Considering the fact that our project this year had a close relationship with cancer, and the aim of our project was to create a novel clinical application---handy, low-cost blood-microRNA detetion system, we attached great importance to medical professionalism. Thus we turned to doctors from First Xiangya Hospital affiliated to CSU, Second Xiangya Hospital affiliated to CSU and Health Center of NUDT as our medical professional consultant in the whole process of the project.</span> |
</p> | </p> | ||
</br> | </br> | ||
<h3> | <h3> | ||
− | + | <span style="color:#7f1015">Interviews with Doctors</span> | |
</h3> | </h3> | ||
− | |||
− | |||
</p> | </p> | ||
</br> | </br> | ||
+ | <h4> | ||
+ | <span style="color:#7f1015">1.Dr.Li Wenjin, Hematology Department, First Xiangya Affiliated Hospital of CSU</span> | ||
+ | </h4> | ||
<p style="text-indent:22pt;"> | <p style="text-indent:22pt;"> | ||
− | <span style="line-height:2;font-family:Perpetua;font-size:18px;"> | + | <span style="line-height:2;font-family:Perpetua;font-size:18px;">(1)Procedure of Current Cancer Detection</span> |
+ | </p> | ||
+ | |||
+ | |||
+ | |||
+ | |||
</p> | </p> | ||
− | |||
<p style="text-indent:22pt;"> | <p style="text-indent:22pt;"> | ||
− | <span style="line-height:2;font-family:Perpetua;font-size:18px;"> | + | <span style="line-height:2;font-family:Perpetua;font-size:18px;">Dr.Li mentions the procedure of current cancer detection,including extracting DNA from blood cells, amplifying it with PCR and then getting its sequences.Detection varies from diseases and gene chip(detection for all genes) also could be applied with enough money.However, only some genes are of necessity to be detected for individuals.</span> |
</p> | </p> | ||
</br> | </br> | ||
− | |||
<p style="text-indent:22pt;"> | <p style="text-indent:22pt;"> | ||
− | <span style="line-height:2;font-family:Perpetua;font-size:18px;"> | + | <span style="line-height:2;font-family:Perpetua;font-size:18px;">(2)Gap Exists Between Clinical Application and Basic Research </span> |
</p> | </p> | ||
− | |||
− | |||
<p style="text-indent:22pt;"> | <p style="text-indent:22pt;"> | ||
− | <span style="line-height:2;font-family:Perpetua;font-size:18px;"> | + | <span style="line-height:2;font-family:Perpetua;font-size:18px;">There was distance between clinical application and basic research in early detection of cancer. For instance, some means of early cancer detection still had a long way to go before proved efficacious---commonly 5-10 years experimental validation phase is integral to clinical application.</span> |
</p> | </p> | ||
− | |||
− | |||
<p style="text-indent:22pt;"> | <p style="text-indent:22pt;"> | ||
− | <span style="line-height:2;font-family:Perpetua;font-size:18px;"> | + | <span style="line-height:2;font-family:Perpetua;font-size:18px;">(3)Stability of MiRNA in Blood is Doubted</span> |
+ | </p> | ||
+ | |||
+ | |||
+ | |||
+ | |||
</p> | </p> | ||
− | |||
<p style="text-indent:22pt;"> | <p style="text-indent:22pt;"> | ||
− | <span style="line-height:2;font-family:Perpetua;font-size:18px;"> | + | <span style="line-height:2;font-family:Perpetua;font-size:18px;">Dr.Li shows her concern about the instability of miRNA when the topic is involved with miRNA and its potential application in early detection of cancer.However,she also mentions that as a clinical doctor,she doesn’t have much research time so that she is not expert in miRNA field.Meanwhile,Dr.Li says that they clinical doctors usually pay more attention on developed technology instead of the developing one and her knowledge about miRNA comes from papers.</span> |
− | </span> | + | |
</p> | </p> | ||
</br> | </br> | ||
− | |||
<p style="text-indent:22pt;"> | <p style="text-indent:22pt;"> | ||
− | <span style="line-height:2;font-family:Perpetua;font-size:18px;"> | + | <span style="line-height:2;font-family:Perpetua;font-size:18px;">(4)Efficiency of MiRNA Detection is Not Guaranteed</span> |
</p> | </p> | ||
− | |||
− | |||
− | |||
− | |||
− | + | ||
− | + | ||
</p> | </p> | ||
− | |||
<p style="text-indent:22pt;"> | <p style="text-indent:22pt;"> | ||
− | <span style="line-height:2;font-family:Perpetua;font-size:18px;"> | + | <span style="line-height:2;font-family:Perpetua;font-size:18px;">Dr.Li says that they clinician commonly assess the severity not only by the gene detection,but also by patients’ clinical symptoms,chromosome. The oncologists even need to do the Immunohistochemical checker and pathology section to make sure.So they suspect a bit about the efficiency of early cancer detection due to the lack of pathological symptoms and currently so-so specified biomarkers in patients’ early stage.</span> |
</p> | </p> | ||
</br> | </br> | ||
<p style="text-indent:22pt;"> | <p style="text-indent:22pt;"> | ||
− | <span style="line-height:2;font-family:Perpetua;font-size:18px;"> | + | <span style="line-height:2;font-family:Perpetua;font-size:18px;">(5)Prospect of MiRNA Is Expected</span> |
</p> | </p> | ||
− | |||
− | + | ||
− | + | ||
+ | |||
</p> | </p> | ||
− | |||
<p style="text-indent:22pt;"> | <p style="text-indent:22pt;"> | ||
− | <span style="line-height:2;font-family:Perpetua;font-size:18px;"> | + | <span style="line-height:2;font-family:Perpetua;font-size:18px;">Dr.Li hopes that the team of NUDT_CHINA would find a way to detect cancer, with much greater specificity and fewer side effects, so that more targeted medicine could be invented to kill cancer tumors. |
+ | She also figures that early cancer detection could help people carried with household hereditary disease factors.Additionally, the index of miRNA could help alert people to pay more attention to their living habits and health condition as well.</span> | ||
</p> | </p> | ||
</br> | </br> | ||
− | < | + | |
− | + | <h4> | |
− | </ | + | <span style="color:#7f1015">2.Dr.Hou Tao, Oncology Department,Second Xiangya Affiliated Hospital of CSU</span> |
− | + | </h4></span> | |
− | + | </h4> | |
− | + | ||
+ | |||
− | |||
− | |||
</p> | </p> | ||
</br> | </br> | ||
− | |||
− | |||
− | |||
<p style="text-indent:22pt;"> | <p style="text-indent:22pt;"> | ||
− | <span style="line-height:2;font-family:Perpetua;font-size:18px;"> | + | <span style="line-height:2;font-family:Perpetua;font-size:18px;">(1)Current situation of tumor biomarker test</span> |
</p> | </p> | ||
</br> | </br> | ||
+ | </p> | ||
+ | </br> | ||
<p style="text-indent:22pt;"> | <p style="text-indent:22pt;"> | ||
− | <span style="line-height:2;font-family:Perpetua;font-size:18px;"> | + | <span style="line-height:2;font-family:Perpetua;font-size:18px;">We asked Dr.Hou about some details about current tumor biomarker test the hospital usuallly suggested patients to take. And this helped us learn more about the current situation of tumor biomarker test.</span> |
</p> | </p> | ||
</br> | </br> | ||
− | |||
− | |||
− | |||
− | |||
− | |||
</p> | </p> | ||
</br> | </br> | ||
<p style="text-indent:22pt;"> | <p style="text-indent:22pt;"> | ||
− | <span style="line-height:2;font-family:Perpetua;font-size:18px;"></span> | + | <span style="line-height:2;font-family:Perpetua;font-size:18px;">a.Biomarker tests in health exams</span> |
</p> | </p> | ||
</br> | </br> | ||
− | + | ||
− | + | ||
</p> | </p> | ||
</br> | </br> | ||
<p style="text-indent:22pt;"> | <p style="text-indent:22pt;"> | ||
− | <span style="line-height:2;font-family:Perpetua;font-size:18px;"></span> | + | <span style="line-height:2;font-family:Perpetua;font-size:18px;">In a normal health exam, there is an optional choice of tumor biomarker test including tests for 12 biomarkers of most frequent cancers, which is called ‘set 12’ by doctors. Talking about taking the biomarker tests, Dr.Hou said that the popularity of biomarker tests was increasing in oncology department in hospitals in China. And with more people getting familiar with tumor biomarker test, it was gaining increasing attention, and a great number of healthy people requested tumor biomarker test in their health exams, especially the elder. Tumor biomarker tests are gaining increasing attention from the crowd.</span> |
</p> | </p> | ||
</br> | </br> | ||
− | + | ||
− | + | ||
</p> | </p> | ||
</br> | </br> | ||
<p style="text-indent:22pt;"> | <p style="text-indent:22pt;"> | ||
− | <span style="line-height:2;font-family:Perpetua;font-size:18px;"></span> | + | <span style="line-height:2;font-family:Perpetua;font-size:18px;">b.Details of a normal biomarker test in health exams</span> |
</p> | </p> | ||
</br> | </br> | ||
− | + | ||
− | + | ||
</p> | </p> | ||
</br> | </br> | ||
<p style="text-indent:22pt;"> | <p style="text-indent:22pt;"> | ||
− | <span style="line-height:2;font-family:Perpetua;font-size:18px;"></span> | + | <span style="line-height:2;font-family:Perpetua;font-size:18px;">Contents of ‘set 12’ biomarker test in a normal health exam:</span> |
+ | </p> | ||
+ | |||
+ | |||
+ | <p> | ||
+ | <table class="MsoTableGrid" style="width:414.2pt;"> | ||
+ | <tbody> | ||
+ | <tr> | ||
+ | <td width="284" valign="center" style="border:1.0000pt solid windowtext;"> | ||
+ | <p class="p" align="center" style="text-align:center;"> | ||
+ | <span style="font-family:'Arial Black';color:#000000;font-size:12pt;">CA19-9</span><span style="font-family:宋体;color:#C00000;font-size:12.0000pt;"></span> | ||
+ | </p> | ||
+ | </td> | ||
+ | <td width="284" valign="center" style="border:1.0000pt solid windowtext;"> | ||
+ | <p class="p" align="center" style="text-align:center;"> | ||
+ | <span style="font-family:'Arial Black';color:#000000;font-size:12pt;">Beta-HCG</span><span style="font-family:宋体;color:#C00000;font-size:12.0000pt;"></span> | ||
+ | </p> | ||
+ | </td> | ||
+ | <td width="260" valign="center" style="border:1.0000pt solid windowtext;"> | ||
+ | <p class="p" align="center" style="margin-left:0.0000pt;text-align:center;"> | ||
+ | <span style="font-family:'Arial Black';color:#000000;font-size:12pt;">CA125</span><span style="font-family:宋体;color:#C00000;font-size:12.0000pt;"></span> | ||
+ | </p> | ||
+ | </td> | ||
+ | </tr> | ||
+ | <tr> | ||
+ | <td width="284" valign="center" style="border:1.0000pt solid windowtext;"> | ||
+ | <p class="p" align="center" style="text-align:center;"> | ||
+ | <span style="font-family:Arial;color:#000000;font-size:12pt;">NSE</span><span style="font-family:宋体;color:#C00000;font-size:12.0000pt;"></span> | ||
+ | </p> | ||
+ | </td> | ||
+ | <td width="284" valign="center" style="border:1.0000pt solid windowtext;"> | ||
+ | <p class="p" align="center" style="text-align:center;"> | ||
+ | <span style="font-family:Arial;color:#000000;font-size:12pt;">AFPHY</span><span style="font-family:宋体;color:#C00000;font-size:12.0000pt;"></span> | ||
+ | </p> | ||
+ | </td> | ||
+ | <td width="260" valign="center" style="border:1.0000pt solid windowtext;"> | ||
+ | <p class="p" align="center" style="margin-left:0.0000pt;text-align:center;"> | ||
+ | <span style="font-family:Arial;color:#000000;font-size:12pt;">Ferritin</span><span style="font-family:宋体;color:#C00000;font-size:12.0000pt;"></span> | ||
+ | </p> | ||
+ | </td> | ||
+ | </tr> | ||
+ | <tr> | ||
+ | <td width="284" valign="center" style="border:1.0000pt solid windowtext;"> | ||
+ | <p class="p" align="center" style="text-align:center;"> | ||
+ | <span style="font-family:Arial;color:#000000;font-size:12pt;">CEA</span><span style="font-family:宋体;color:#C00000;font-size:12.0000pt;"></span> | ||
+ | </p> | ||
+ | </td> | ||
+ | <td width="284" valign="center" style="border:1.0000pt solid windowtext;"> | ||
+ | <p class="p" align="center" style="text-align:center;"> | ||
+ | <span style="font-family:Arial;color:#000000;font-size:12pt;">Free-PSA</span><span style="font-family:宋体;color:#C00000;font-size:12.0000pt;"></span> | ||
+ | </p> | ||
+ | </td> | ||
+ | <td width="260" valign="center" style="border:1.0000pt solid windowtext;"> | ||
+ | <p class="p" align="center" style="text-align:center;"> | ||
+ | <span style="font-family:Arial;color:#000000;font-size:12pt;">HGH</span><span style="font-family:宋体;color:#C00000;font-size:12.0000pt;"></span> | ||
+ | </p> | ||
+ | </td> | ||
+ | </tr> | ||
+ | <tr> | ||
+ | <td width="284" valign="center" style="border:1.0000pt solid windowtext;"> | ||
+ | <p class="p" align="center" style="text-align:center;"> | ||
+ | <span style="font-family:Arial;color:#000000;font-size:12pt;">CA242</span><span style="font-family:宋体;color:#C00000;font-size:12.0000pt;"></span> | ||
+ | </p> | ||
+ | </td> | ||
+ | <td width="284" valign="center" style="border:1.0000pt solid windowtext;"> | ||
+ | <p class="p" align="center" style="text-align:center;"> | ||
+ | <span style="font-family:Arial;color:#000000;font-size:12pt;">PSA</span><span style="font-family:宋体;color:#C00000;font-size:12.0000pt;"></span> | ||
+ | </p> | ||
+ | </td> | ||
+ | <td width="260" valign="center" style="border:1.0000pt solid windowtext;"> | ||
+ | <p class="p" align="center" style="text-align:center;"> | ||
+ | <span style="font-family:Arial;color:#000000;font-size:12pt;">CA15-3</span><span style="font-family:宋体;color:#C00000;font-size:12.0000pt;"></span> | ||
+ | </p> | ||
+ | </td> | ||
+ | </tr> | ||
+ | </tbody> | ||
+ | </table> | ||
+ | <br /> | ||
+ | <span style="background-color:;"><span style="color:#000000;"></span></span> | ||
+ | </p> | ||
+ | <p> | ||
+ | <br /> | ||
+ | </p> | ||
+ | |||
+ | |||
+ | |||
+ | |||
</p> | </p> | ||
</br> | </br> | ||
<p style="text-indent:22pt;"> | <p style="text-indent:22pt;"> | ||
− | <span style="line-height:2;font-family:Perpetua;font-size:18px;"></span> | + | <span style="line-height:2;font-family:Perpetua;font-size:18px;">Cost of the test for 12 biomarkers, or the ‘set 12’ is ¥500, including biomarkers of breast cancer, liver cancer and so on. Dr.Hou also told us that the validness of biomarkers was not so optimistic, thus could only work as a reference for diagnosis of cancers.</span> |
</p> | </p> | ||
</br> | </br> | ||
− | + | ||
− | + | ||
</p> | </p> | ||
</br> | </br> | ||
Line 670: | Line 669: | ||
</p> | </p> | ||
</br> | </br> | ||
− | + | ||
− | + | ||
</p> | </p> | ||
</br> | </br> | ||
Line 678: | Line 676: | ||
</p> | </p> | ||
</br> | </br> | ||
− | + | ||
− | + | ||
</p> | </p> | ||
</br> | </br> | ||
Line 686: | Line 683: | ||
</p> | </p> | ||
</br> | </br> | ||
− | + | ||
− | + | ||
</p> | </p> | ||
</br> | </br> | ||
Line 694: | Line 690: | ||
</p> | </p> | ||
</br> | </br> | ||
− | + | ||
− | + | ||
</p> | </p> | ||
</br> | </br> | ||
Line 702: | Line 697: | ||
</p> | </p> | ||
</br> | </br> | ||
− | + | ||
− | + | ||
</p> | </p> | ||
</br> | </br> | ||
Line 710: | Line 704: | ||
</p> | </p> | ||
</br> | </br> | ||
− | + | ||
− | + | ||
</p> | </p> | ||
</br> | </br> | ||
Line 718: | Line 711: | ||
</p> | </p> | ||
</br> | </br> | ||
− | + | ||
− | + | ||
</p> | </p> | ||
</br> | </br> | ||
Line 726: | Line 718: | ||
</p> | </p> | ||
</br> | </br> | ||
− | + | ||
− | + | ||
</p> | </p> | ||
</br> | </br> | ||
Line 734: | Line 725: | ||
</p> | </p> | ||
</br> | </br> | ||
− | + | ||
− | + | ||
</p> | </p> | ||
</br> | </br> | ||
Line 742: | Line 732: | ||
</p> | </p> | ||
</br> | </br> | ||
− | + | ||
− | + | ||
</p> | </p> | ||
</br> | </br> | ||
Line 750: | Line 739: | ||
</p> | </p> | ||
</br> | </br> | ||
− | + | ||
− | + | ||
</p> | </p> | ||
</br> | </br> | ||
<p style="text-indent:22pt;"> | <p style="text-indent:22pt;"> | ||
<span style="line-height:2;font-family:Perpetua;font-size:18px;"></span> | <span style="line-height:2;font-family:Perpetua;font-size:18px;"></span> | ||
+ | </p> | ||
+ | </br> | ||
+ | |||
</p> | </p> | ||
</br> | </br> | ||
Line 767: | Line 758: | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
Line 812: | Line 770: | ||
</div> | </div> | ||
<!-- end #content-wrap --> | <!-- end #content-wrap --> | ||
− | + | <div style="border:solid 1px rgb(10,31,84);background-color:rgb(10,31,84);"> | |
− | + | <div class="row footer-link" style="border:solid 0px red;margin-top:100px;"> | |
− | + | <style>.menu-link-container ul li{ list-style:none; } .menu-link-container a{ color:white; font-size:14px;line-height:26px; } | |
− | + | .menu-link-container a:hover{ | |
− | + | text-decoration:underline; | |
− | + | } #c_menu9909 .medium-6{ text-align:center; width:auto; border:solid 0px red; } #c_menu9909 .medium-6 h5{color:white;}#c_menu9909 .medium-6{height:315px;border:solid 0px red;}</style> | |
− | + | <div id="c_menu9909"> | |
− | + | <!--div class="medium-6 columns" style="width:auto;"> | |
− | + | <h5 class="column-header">HOME</h5> | |
− | + | <div class="menu-link-container"></div></div--> | |
− | + | <div class="medium-6 columns" style="width:auto;"> | |
− | + | <h5 class="column-header">TEAM</h5> | |
− | + | <div class="menu-link-container"> | |
− | + | ||
− | + | ||
− | + | <a href="/Team:NUDT_CHINA/Team">Team</a><br/> | |
− | + | ||
− | + | <a href="/Team:NUDT_CHINA/Collaborations">Collaborations</a><br/> | |
− | + | ||
− | + | </div> | |
− | + | </div> | |
− | + | <div class="medium-6 columns" style="width:auto;"> | |
− | + | <h5 class="column-header">PROJECT</h5> | |
− | + | <div class="menu-link-container"> | |
− | + | ||
− | + | ||
− | + | <a href="/Team:NUDT_CHINA/Description">Description</a><br/> | |
− | + | ||
− | + | <a href="/Team:NUDT_CHINA/Design">Design</a><br/> | |
− | + | ||
− | + | <a href="/Team:NUDT_CHINA/Experiments">Experiments</a><br/> | |
− | + | ||
− | + | <a href="/Team:NUDT_CHINA/Proof">Proof of Concept</a><br/> | |
− | + | ||
− | + | <a href="/Team:NUDT_CHINA/Demonstrate">Demonstrate</a><br/> | |
− | + | ||
− | + | <a href="/Team:NUDT_CHINA/Results">Results</a><br/> | |
− | + | ||
− | + | <a href="/Team:NUDT_CHINA/Notebook">Notebook</a><br/> | |
− | + | ||
− | + | </div> | |
− | + | </div> | |
− | + | <div class="medium-6 columns" style="width:auto;"> | |
− | + | <h5 class="column-header">PARTS</h5> | |
− | + | <div class="menu-link-container"> | |
− | + | ||
− | + | ||
− | + | <a href="/Team:NUDT_CHINA/Parts">Parts</a><br/> | |
− | + | ||
− | + | <a href="/Team:NUDT_CHINA/Basic_Part">Basic Parts</a><br/> | |
− | + | ||
− | + | <a href="/Team:NUDT_CHINA/Composite_Part">Composite Parts</a><br/> | |
− | + | ||
− | + | <a href="/Team:NUDT_CHINA/Part_Collection">Part Collection</a><br/> | |
− | + | ||
− | + | </div> | |
− | + | </div> | |
− | + | <div class="medium-6 columns" style="width:auto;"> | |
− | + | <a href="/Team:NUDT_CHINA/Safety" style="text-decoration:none;"> | |
− | + | <h5 class="column-header">SAFETY</h5></a> | |
− | + | ||
− | + | </div> | |
− | + | <div class="medium-6 columns" style="width:auto;"> | |
− | + | <a href="/Team:NUDT_CHINA/Attributions" style="text-decoration:none;"> | |
− | + | <h5 class="column-header">ATTRIBUTIONS</h5></a> | |
− | + | ||
− | + | </div> | |
− | + | <!--div class="medium-6 columns" style="width:auto;"> | |
− | + | <A href="/Team:NUDT_CHINA/Attributions" style="text-decoration:none;"><h5 class="column-header">ATTRIBUTIONS</h5></A> | |
− | + | <div class="menu-link-container"></div></div--> | |
− | + | <div class="medium-6 columns" style="width:auto;"> | |
− | + | <h5 class="column-header">HUMAN | |
− | + | <br>PRACTICES</h5> | |
− | + | <div class="menu-link-container"> | |
− | + | ||
− | + | ||
− | + | <a href="/Team:NUDT_CHINA/Human_Practices">Human Practices</a><br/> | |
− | + | ||
− | + | <a href="/Team:NUDT_CHINA/HP/Silver">Silver</a><br/> | |
− | + | ||
− | + | <a href="/Team:NUDT_CHINA/HP/Gold">Gold</a><br/> | |
− | + | ||
− | + | <a href="/Team:NUDT_CHINA/Integrated_Practices">Integrated Practices</a><br/> | |
− | + | ||
− | + | <a href="/Team:NUDT_CHINA/Engagement">Engagement</a><br/> | |
− | + | ||
− | + | </div> | |
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
</div> | </div> | ||
+ | <div class="medium-6 columns" style="width:auto;"> | ||
+ | <h5 class="column-header">AWARDS</h5> | ||
+ | <div class="menu-link-container"> | ||
+ | |||
+ | |||
+ | <a href="/Team:NUDT_CHINA/Model">Model</a><br/> | ||
+ | |||
+ | </div> | ||
+ | </div> | ||
+ | <div class="medium-6 columns" style="width:0px;height:0px;"></div> | ||
+ | </div> | ||
+ | </div> | ||
+ | </div> | ||
<footer id="footer"> | <footer id="footer"> | ||
<div class="row footer-link"> | <div class="row footer-link"> | ||
Line 962: | Line 921: | ||
--> | --> | ||
− | + | <!-- to top edit by inksci---> | |
+ | <style> | ||
+ | #to_top{ | ||
+ | position:fixed; | ||
+ | bottom:100px; | ||
+ | right:0px; | ||
+ | width:60px; | ||
+ | height:60px; | ||
+ | font-size:14px; | ||
+ | line-height:60px; | ||
+ | text-align:center; | ||
+ | background-color:black; | ||
+ | color:rgb(246,168,0); | ||
+ | cursor:pointer; | ||
+ | } | ||
+ | </style> | ||
+ | <div onclick="top_it()" id="to_top"> | ||
+ | TOP | ||
+ | </div> | ||
+ | <script type="text/javascript"> | ||
+ | var oTop = document.getElementById("to_top"); | ||
+ | oTop.style.display="none"; | ||
+ | var top_break=false; | ||
+ | /** | ||
+ | * 回到页面顶部 | ||
+ | * @param acceleration 加速度 | ||
+ | * @param time 时间间隔 (毫秒) | ||
+ | **/ | ||
+ | var save_scrolltop=100000000000000; | ||
+ | window.onscroll = function(){ | ||
+ | |||
+ | |||
+ | var scrolltop = document.documentElement.scrollTop || document.body.scrollTop; | ||
+ | if(scrolltop>300){ | ||
+ | oTop.style.display="block"; | ||
+ | }else{ | ||
+ | oTop.style.display="none"; | ||
+ | } | ||
+ | if(scrolltop>save_scrolltop) | ||
+ | { | ||
+ | top_break=true; | ||
+ | } | ||
+ | save_scrolltop=scrolltop; | ||
+ | } | ||
+ | function top_it(){ | ||
+ | top_break=false; | ||
+ | goTop();return false; | ||
+ | } | ||
+ | function goTop(acceleration, time) { | ||
+ | if(top_break){ | ||
+ | return; | ||
+ | } | ||
+ | oTop.style.display="none"; | ||
+ | acceleration = acceleration || 0.1; | ||
+ | time = time || 16; | ||
+ | |||
+ | var x1 = 0; | ||
+ | var y1 = 0; | ||
+ | var x2 = 0; | ||
+ | var y2 = 0; | ||
+ | var x3 = 0; | ||
+ | var y3 = 0; | ||
+ | |||
+ | if (document.documentElement) { | ||
+ | x1 = document.documentElement.scrollLeft || 0; | ||
+ | y1 = document.documentElement.scrollTop || 0; | ||
+ | } | ||
+ | if (document.body) { | ||
+ | x2 = document.body.scrollLeft || 0; | ||
+ | y2 = document.body.scrollTop || 0; | ||
+ | } | ||
+ | var x3 = window.scrollX || 0; | ||
+ | var y3 = window.scrollY || 0; | ||
+ | |||
+ | // 滚动条到页面顶部的水平距离 | ||
+ | var x = Math.max(x1, Math.max(x2, x3)); | ||
+ | // 滚动条到页面顶部的垂直距离 | ||
+ | var y = Math.max(y1, Math.max(y2, y3)); | ||
+ | |||
+ | // 滚动距离 = 目前距离 / 速度, 因为距离原来越小, 速度是大于 1 的数, 所以滚动距离会越来越小 | ||
+ | var speed = 1 + acceleration; | ||
+ | window.scrollTo(Math.floor(x / speed), Math.floor(y / speed)); | ||
+ | |||
+ | // 如果距离不为零, 继续调用迭代本函数 | ||
+ | if(x > 0 || y > 0) { | ||
+ | var invokeFunction = "goTop(" + acceleration + ", " + time + ")"; | ||
+ | window.setTimeout(invokeFunction, time); | ||
+ | } | ||
+ | } | ||
+ | </script> | ||
+ | <!-- to top edit by inksci---> | ||
</body> | </body> | ||
</html> | </html> |
Revision as of 03:15, 19 October 2016
TOP